Although they also showed that BCKDK inhibitor can increase BCKD activity, reduce plasma levels of BCAAs and BCKAs, and improve insulin sensitivity in DIO mice, this intervention did not reduce obesity. This evidence concerns the gene BCKDK and obesity due to melanocortin 4 receptor deficiency.